AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2014
Jul 7, 2014
30718_dirs_2014-07-07_2e465e97-4a31-46dd-9881-cb85ee1da82b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2014-07-02
Reporting Person: EANSOR N DAVID (SVP - Novus Biologicals)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-02 | Restricted Stock Units | $ | A | 5000 | Acquired | Common Stock (5000) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Techne Corporation common stock.
F2: The restricted stock units vest in three equal annual installments beginning July 1, 2015. Shares will be delivered to the reporting person following vesting.
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4